Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection?

Alan H.B. Wu; Peter A. Kavsak; Kristin Moberg Aakre; Robert H. Christenson; DIna N. Greene; Fred S. Apple; W. Frank Peacock; Judd E. Hollander; James A. De Lemos; David Morrow; James Januzzi; Allan S. Jaffe

doi:10.1093/clinchem/hvaa160

Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection?

Alan H.B. Wu, Peter A. Kavsak, Kristin Moberg Aakre, Robert H. Christenson, DIna N. Greene, Fred S. Apple, W. Frank Peacock, Judd E. Hollander, James A. De Lemos, David Morrow, James Januzzi, Allan S. Jaffe

Cardiovascular Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1146-1149
Number of pages	4
Journal	Clinical chemistry
Volume	66
Issue number	9
DOIs	https://doi.org/10.1093/clinchem/hvaa160
State	Published - Sep 1 2020

ASJC Scopus subject areas

Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1093/clinchem/hvaa160

Cite this

Wu, A. H. B., Kavsak, P. A., Aakre, K. M., Christenson, R. H., Greene, DI. N., Apple, F. S., Peacock, W. F., Hollander, J. E., De Lemos, J. A., Morrow, D., Januzzi, J., & Jaffe, A. S. (2020). Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection? Clinical chemistry, 66(9), 1146-1149. https://doi.org/10.1093/clinchem/hvaa160

Wu, AHB, Kavsak, PA, Aakre, KM, Christenson, RH, Greene, DIN, Apple, FS, Peacock, WF, Hollander, JE, De Lemos, JA, Morrow, D, Januzzi, J & Jaffe, AS 2020, 'Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection?', Clinical chemistry, vol. 66, no. 9, pp. 1146-1149. https://doi.org/10.1093/clinchem/hvaa160

@article{4688efa96e9f48f3a920930fc4ea816b,

title = "Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection?",

author = "Wu, {Alan H.B.} and Kavsak, {Peter A.} and Aakre, {Kristin Moberg} and Christenson, {Robert H.} and Greene, {DIna N.} and Apple, {Fred S.} and Peacock, {W. Frank} and Hollander, {Judd E.} and {De Lemos}, {James A.} and David Morrow and James Januzzi and Jaffe, {Allan S.}",

year = "2020",

month = sep,

day = "1",

doi = "10.1093/clinchem/hvaa160",

language = "English (US)",

volume = "66",

pages = "1146--1149",

journal = "Clinical chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "9",

}

TY - JOUR

T1 - Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin

T2 - Can We Realistically Report Down to the Assay's Limit of Detection?

AU - Wu, Alan H.B.

AU - Kavsak, Peter A.

AU - Aakre, Kristin Moberg

AU - Christenson, Robert H.

AU - Greene, DIna N.

AU - Apple, Fred S.

AU - Peacock, W. Frank

AU - Hollander, Judd E.

AU - De Lemos, James A.

AU - Morrow, David

AU - Januzzi, James

AU - Jaffe, Allan S.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85090252360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090252360&partnerID=8YFLogxK

U2 - 10.1093/clinchem/hvaa160

DO - 10.1093/clinchem/hvaa160

M3 - Comment/debate

C2 - 32785711

AN - SCOPUS:85090252360

SN - 0009-9147

VL - 66

SP - 1146

EP - 1149

JO - Clinical chemistry

JF - Clinical chemistry

IS - 9

ER -

Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this